Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Non‐steroidal anti‐inflammatory drugs, prostaglandins, and COVID‐19
Calum T. Robb, Marie Goepp, Adriano G. Rossi, et al.
British Journal of Pharmacology (2020) Vol. 177, Iss. 21, pp. 4899-4920
Open Access | Times Cited: 93

Showing 1-25 of 93 citing articles:

Epidemiology, pathogenesis, clinical presentations, diagnosis and treatment of COVID-19: a review of current evidence
Sayeeda Rahman, Maria Teresa Villagomez Montero, Kherie Rowe, et al.
Expert Review of Clinical Pharmacology (2021) Vol. 14, Iss. 5, pp. 601-621
Open Access | Times Cited: 250
Nonsteroidal Anti-inflammatory Drugs Dampen the Cytokine and Antibody Response to SARS-CoV-2 Infection
Jennifer Chen, Mia Madel Alfajaro, Ryan D. Chow, et al.
Journal of Virology (2021) Vol. 95, Iss. 7
Open Access | Times Cited: 135
Non-steroidal anti-inflammatory drugs: recent advances in the use of synthetic COX-2 inhibitors
Mohsen Ahmadi, Sander Bekeschus, Klaus‐Dieter Weltmann, et al.
RSC Medicinal Chemistry (2022) Vol. 13, Iss. 5, pp. 471-496
Open Access | Times Cited: 100
Neutrophil elastase: From mechanisms to therapeutic potential
Weilin Zeng, Yingqiu Song, Runze Wang, et al.
Journal of Pharmaceutical Analysis (2023) Vol. 13, Iss. 4, pp. 355-366
Open Access | Times Cited: 65
Neutrophil Extracellular Traps and By-Products Play a Key Role in COVID-19: Pathogenesis, Risk Factors, and Therapy
Alain R. Thierry, Benoît Roch
Journal of Clinical Medicine (2020) Vol. 9, Iss. 9, pp. 2942-2942
Open Access | Times Cited: 116
Core–Shell Eudragit S100 Nanofibers Prepared via Triaxial Electrospinning to Provide a Colon-Targeted Extended Drug Release
Yanfei Ding, Cheng Dou, Shuyue Chang, et al.
Polymers (2020) Vol. 12, Iss. 9, pp. 2034-2034
Open Access | Times Cited: 98
Potential Role of Antioxidant and Anti-Inflammatory Therapies to Prevent Severe SARS-Cov-2 Complications
Anna Maria Fratta Pasini, Chiara Stranieri, Luciano Cominacini, et al.
Antioxidants (2021) Vol. 10, Iss. 2, pp. 272-272
Open Access | Times Cited: 61
Differential Co-Expression Network Analysis Reveals Key Hub-High Traffic Genes as Potential Therapeutic Targets for COVID-19 Pandemic
Aliakbar Hasankhani, Abolfazl Bahrami, Negin Sheybani, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 51
Alteration in the Lipid Profile and the Desaturases Activity in Patients With Severe Pneumonia by SARS-CoV-2
Israel Pérez-Torres, Verónica Guarner‐Lans, Elizabeth Soria‐Castro, et al.
Frontiers in Physiology (2021) Vol. 12
Open Access | Times Cited: 41
Antiviral Properties of the NSAID Drug Naproxen Targeting the Nucleoprotein of SARS-CoV-2 Coronavirus
Olivier Terrier, Sébastien Dilly, Andrés Pizzorno, et al.
Molecules (2021) Vol. 26, Iss. 9, pp. 2593-2593
Open Access | Times Cited: 38
Assessment of Galectin-1, Galectin-3, and Prostaglandin E2 Levels in Patients with COVID-19
Sümeyye Kazancıoğlu, Fatma Yılmaz, Aliye Baştuğ, et al.
Japanese Journal of Infectious Diseases (2021) Vol. 74, Iss. 6, pp. 530-536
Open Access | Times Cited: 36
Psychological and Cognitive Effects of Long COVID: A Narrative Review Focusing on the Assessment and Rehabilitative Approach
Rosaria De Luca, Mirjam Bonanno, Rocco Salvatore Calabrò
Journal of Clinical Medicine (2022) Vol. 11, Iss. 21, pp. 6554-6554
Open Access | Times Cited: 23
Pharmacogenetics and Precision Medicine Approaches for the Improvement of COVID-19 Therapies
Mohitosh Biswas, Nares Sawajan, Thanyada Rungrotmongkol, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 22
Serum lipid mediator profiles in COVID-19 patients and lung disease severity: a pilot study
Pilar Irún, Rafael Gracia, Elena Piazuelo, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 13
Prostaglandin E2/Leukotriene B4 balance and viral load in distinct clinical stages of COVID-19: A cross-sectional study
Larisse Ricardo Gadelha, Maria Juliana Bezerra Costa, João Paulo Alecrim de Abreu, et al.
Prostaglandins & Other Lipid Mediators (2024) Vol. 172, pp. 106820-106820
Closed Access | Times Cited: 4
EP2 Antagonists (2011–2021): A Decade’s Journey from Discovery to Therapeutics
Madison N. Sluter, R. Hou, Lexiao Li, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 16, pp. 11816-11836
Open Access | Times Cited: 28
Targeting cyclooxygenase enzyme for the adjuvant COVID‐19 therapy
Parteek Prasher, Mousmee Sharma, Ravi Gunupuru
Drug Development Research (2021) Vol. 82, Iss. 4, pp. 469-473
Open Access | Times Cited: 27
In Vitro Assessment of the Antiviral Activity of Ketotifen, Indomethacin and Naproxen, Alone and in Combination, against SARS-CoV-2
Pantea Kiani, Andrew Scholey, Thomas A. Dahl, et al.
Viruses (2021) Vol. 13, Iss. 4, pp. 558-558
Open Access | Times Cited: 27
Association between COVID-19 Diagnosis and Coronary Artery Thrombosis: A Narrative Review
Francesco Nappi, Omar Giacinto, Omar Ellouze, et al.
Biomedicines (2022) Vol. 10, Iss. 3, pp. 702-702
Open Access | Times Cited: 20
Drug repurposing: re-inventing therapies for cancer without re-entering the development pipeline—a review
Shafina Siddiqui, Ankita Jaywant Deshmukh, Priyanka Mudaliar, et al.
Journal of the Egyptian National Cancer Institute (2022) Vol. 34, Iss. 1
Open Access | Times Cited: 20
Pulmonary endothelium-targeted nanoassembly of indomethacin and superoxide dismutase relieves lung inflammation
Yi Yang, Makhloufi Zoulikha, Qingqing Xiao, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 13, Iss. 11, pp. 4607-4620
Open Access | Times Cited: 11
Ketoprofen as an emerging contaminant: occurrence, ecotoxicity and (bio)removal
Elena A. Tyumina, Maria Subbotina, Maxim Polygalov, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 10
Parental (F0) exposure to Cadmium and Ketoprofen induces developmental deformities in offspring (F1): A transgenerational toxicity assessment in zebrafish model
S. Madesh, Gokul Sudhakaran, Raghul Murugan, et al.
The Science of The Total Environment (2024) Vol. 950, pp. 175319-175319
Closed Access | Times Cited: 3
Cytokine storm in the pathophysiology of COVID-19: Possible functional disturbances of miRNAs
Mona Aslani, Seyed Shahabeddin Mortazavi‐Jahromi, Abbas Mirshafiey
International Immunopharmacology (2021) Vol. 101, pp. 108172-108172
Open Access | Times Cited: 26
Page 1 - Next Page

Scroll to top